Journal
AMERICAN JOURNAL OF ROENTGENOLOGY
Volume 193, Issue 4, Pages W301-W307Publisher
AMER ROENTGEN RAY SOC
DOI: 10.2214/AJR.08.2289
Keywords
diffusion-weighted imaging; hepatocellular carcinoma; sorafenib; treatment monitoring
Ask authors/readers for more resources
OBJECTIVE. The objective of our study was to evaluate signal changes of advanced hepatocellular carcinoma in diffusion-weighted MRI in the early-response monitoring of oral therapy with the multikinase inhibitor sorafenib. CONCLUSION. Hepatocellular carcinoma lesions exhibit characteristic but unusual apparent diffusion coefficient (ADC) changes during sorafenib therapy, consisting of early decrease in ADC after therapy onset followed by a reincrease. The ADC changes seem to reflect the underlying pathophysiologic mechanisms in tumor necrosis (most probably hemorrhagic) induced by this novel targeted agent early after therapy onset and may indicate tumor reactivation in the later follow-up period.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available